Logo image of FENC

FENNEC PHARMACEUTICALS INC (FENC) Stock Earnings & Estimates

NASDAQ:FENC - CA31447P1009 - Common Stock

8.87 USD
0 (0%)
Last: 8/29/2025, 8:20:58 PM
8.87 USD
0 (0%)
After Hours: 8/29/2025, 8:20:58 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
FENC revenue by date.FENC revenue by date.
1.54M21.252M
1,280.00%
47.538M
123.69%
47.995M
0.96%
72.812M
51.71%
86.385M
18.64%
123.05M
42.44%
177.51M
44.26%
181.04M
1.99%
185.46M
2.44%
187.64M
1.18%
EBITDA
YoY % growth
FENC ebitda by date.FENC ebitda by date.
N/AN/AN/A
216.67%
17.646M
147.14%
30.906M
75.14%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
FENC ebit by date.FENC ebit by date.
-22.59M
-31.18%
-12.771M
43.47%
2.568M
120.11%
2.74M
6.70%
20.835M
660.40%
33.494M
60.76%
62.917M
87.85%
111.96M
77.95%
110.8M
-1.04%
126.52M
14.19%
137.91M
9.00%
Operating Margin
FENC operating margin by date.FENC operating margin by date.
-1,466.88%-60.09%5.40%5.71%28.61%38.77%51.13%63.07%61.20%68.22%73.50%
EPS
YoY % growth
FENC eps by date.FENC eps by date.
-0.90
-34.33%
-0.61
32.22%
0.00
100.00%
0.09
169,782,103,072,165,900.00%
0.74
683.12%
1.22
65.15%
3.14
157.74%
4.48
42.53%
5.14
14.81%
5.46
6.15%
5.81
6.54%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.07
134.00%
0.12
305.36%
0.08
296.35%
0.13
214.98%
0.18
149.64%
0.30
142.96%
0.15
94.81%
0.20
61.29%
0.23
31.62%
0.59
97.61%
Revenue
Q2Q % growth
13.7M
96.44%
15.112M
90.69%
14.798M
69.10%
16.457M
70.50%
17.939M
30.94%
21.944M
45.21%
18.033M
21.86%
19.012M
15.53%
20.155M
12.35%
26.183M
19.32%
EBITDA
Q2Q % growth
2.448M
1,300.00%
13.566M
2,560.00%
3.264M
346.15%
4.386M
377.78%
5.61M
129.17%
16.932M
24.81%
5.61M
71.88%
7.14M
62.79%
8.262M
47.27%
18.87M
11.45%
EBIT
Q2Q % growth
2.474M
147.58%
3.848M
511.99%
2.665M
429.83%
3.295M
220.61%
4.046M
63.54%
9.776M
154.05%
4.488M
68.41%
6.018M
82.64%
7.14M
76.47%
17.748M
81.55%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.11
45.00%
-0.04-0.07-199.56%
Q1 2025
Q2Q % growth
-0.04
-108.51%
-0.090.0555.84%
Q4 2024
Q2Q % growth
-0.06
40.00%
0.17-0.23-135.44%
Q3 2024
Q2Q % growth
-0.21
-200.00%
-0.09-0.12-128.76%
Q2 2024
Q2Q % growth
-0.20
4.76%
-0.03-0.17-539.32%
Q1 2024
Q2Q % growth
0.47
304.35%
0.270.2075.87%
Q4 2023
Q2Q % growth
-0.10
61.54%
-0.02-0.08-400.20%
Q3 2023
Q2Q % growth
-0.07
77.42%
-0.120.0542.81%
Q2 2023
Q2Q % growth
-0.21
-10.53%
-0.16-0.05-31.55%
Q1 2023
Q2Q % growth
-0.23
-64.29%
-0.21-0.02-7.48%
Q4 2022
Q2Q % growth
-0.26
-44.44%
-0.270.013.75%
Q3 2022
Q2Q % growth
-0.31
-93.75%
-0.19-0.12-67.29%
Q2 2022
Q2Q % growth
-0.19
-26.67%
-0.14-0.05-36.30%
Q1 2022
Q2Q % growth
-0.14
22.22%
-0.140.001.96%
Q4 2021
Q2Q % growth
-0.18
-38.46%
0.76-0.94-123.61%
Q3 2021
Q2Q % growth
-0.16
33.33%
-0.170.017.73%
Q2 2021
Q2Q % growth
-0.15
28.57%
-0.190.0421.78%
Q1 2021
Q2Q % growth
-0.18
5.26%
-0.13-0.05-35.75%
Q4 2020
Q2Q % growth
-0.13
27.78%
-0.190.0632.92%
Q3 2020
Q2Q % growth
-0.24
-166.67%
-0.19-0.05-23.84%
Q2 2020
Q2Q % growth
-0.21
12.50%
-0.18-0.03-16.53%
Q1 2020
Q2Q % growth
-0.19
-46.15%
-0.190.000.21%
Q4 2019
Q2Q % growth
-0.18 -0.13-0.05-35.75%
Q3 2019
Q2Q % growth
-0.09 -0.200.1155.88%
Q2 2019
Q2Q % growth
-0.24 -0.14-0.10-72.16%
Q1 2019
Q2Q % growth
-0.13 -0.160.0316.88%
FENC Yearly EPS VS EstimatesFENC Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
9.652M
32.91%
9.707M-55K-0.57%
Q1 2025
Q2Q % growth
8.751M
-65.52%
8.345M406K4.87%
Q4 2024
Q2Q % growth
7.925M
-18.59%
17.051M-9.126M-53.52%
Q3 2024
Q2Q % growth
6.974M
12.77%
9.162M-2.188M-23.88%
Q2 2024
Q2Q % growth
7.262M
118.41%
11.269M-4.007M-35.56%
Q1 2024
Q2Q % growth
25.377M
1,413.24%
19.254M6.123M31.80%
Q4 2023
Q2Q % growth
9.735M
532.14%
8.843M892K10.09%
Q3 2023
Q2Q % growth
6.184M 5.443M741K13.61%
Q2 2023
Q2Q % growth
3.325M 3.81M-485K-12.73%
Q1 2023
Q2Q % growth
1.677M 1.884M-207K-10.99%
Q4 2022
Q2Q % growth
1.54M 759.727K780.273K102.70%
Q4 2021
Q2Q % growth

-100.00%
34M-34M-100.00%
Q3 2020
Q2Q % growth
484.5K-484.5K-100.00%
FENC Yearly Revenue VS EstimatesFENC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS6% -28.14% -45% -9.94%
Revenue0.73% -20.56% 0.11% 2.37%